2021-2025 Gastrointestinal (GI) Diagnostic Testing Market: US, Europe, Japan-Test Volume and Sales Forecasts, Test Volume by Method (Molecular, Serology/Immunodiagnostics, Culture/Microscopy)
This new report from LeadingMarketResearch.com presents a seven-country strategic analysis of major business opportunities emerging in the GI disease testing market during the next five years. The report reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales by country; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
Rationale
This comprehensive seven-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding GI testing market, in evaluating emerging opportunities and developing effective business strategies.
Worldwide Market Overview
France, Germany, Italy, Japan, Spain, UK, USA
Current and Emerging Products
In-depth examination of major GI diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.
Technology Review
Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
Rationale
This comprehensive seven-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding GI testing market, in evaluating emerging opportunities and developing effective business strategies.
Worldwide Market Overview
- Estimated universe of laboratories performing GI testing by country.
- Test volume and sales projections for major GI assays by country.
- Test volume by method (molecular, serology/immunodiagnostics, culture/microscopy).
- Emerging opportunities for new instrumentation, reagents kits, IT and other products with significant market appeal during the next five years.
- Design criteria for decentralized testing products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Calprotectin
- Campylobacter
- Carbapenemase
- Clostridium
- Cryptosporidium
- E. Coli
- Giardia
- Helicobacter Pylori
- Norovirus
- Rotavirus
- Salmonella
- Vancomycin-Resistant Enterococci
France, Germany, Italy, Japan, Spain, UK, USA
Current and Emerging Products
In-depth examination of major GI diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.
Technology Review
- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for GI testing.
- Global listings of companies developing or marketing GI diagnostic products by individual test.
Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
INTRODUCTION
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
WORLDWIDE OVERVIEW OF MAJOR TESTS, TECHNOLOGIES, AND INSTRUMENTATION
A. Major Gastrointestinal (GI) Tests
1. Campylobacter
2. Clostridium
3. Cryptosporidium
4. E.Coli
5. Giardia
6. Helicobacter Pylori
7. Rotavirus
8. Salmonella
B. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
FRANCE GI TESTING MARKET MARKET SIZE, VOLUME BY METHOD, TEST VOLUME AND SALES FORECASTS
GERMANY GI TESTING MARKET MARKET SIZE, VOLUME BY METHOD, TEST VOLUME AND SALES FORECASTS
ITALY GI TESTING MARKET MARKET SIZE, VOLUME BY METHOD, TEST VOLUME AND SALES FORECASTS
JAPAN GI TESTING MARKET MARKET SIZE, VOLUME BY METHOD, TEST VOLUME AND SALES FORECASTS
SPAIN GI TESTING MARKET MARKET SIZE, VOLUME BY METHOD, TEST VOLUME AND SALES FORECASTS
U.K. GI TESTING MARKET MARKET SIZE, VOLUME BY METHOD, TEST VOLUME AND SALES FORECASTS
U.S.A. GI TESTING MARKET MARKET SIZE, VOLUME BY METHOD, TEST VOLUME AND SALES FORECASTS
COMPETITIVE ASSESSMENTS
Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic
Illumina
Leica Biosystems
Li-Cor Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
PerkinElmer
Proteome Sciences
Qiagen
Quest Diagnostics
Quidel
Roche
Scienion
Sequenom/LabCorp
Shimadzu
Siemens Healthineers
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
Wako Chemical
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
WORLDWIDE OVERVIEW OF MAJOR TESTS, TECHNOLOGIES, AND INSTRUMENTATION
A. Major Gastrointestinal (GI) Tests
1. Campylobacter
2. Clostridium
3. Cryptosporidium
4. E.Coli
5. Giardia
6. Helicobacter Pylori
7. Rotavirus
8. Salmonella
B. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
FRANCE GI TESTING MARKET MARKET SIZE, VOLUME BY METHOD, TEST VOLUME AND SALES FORECASTS
GERMANY GI TESTING MARKET MARKET SIZE, VOLUME BY METHOD, TEST VOLUME AND SALES FORECASTS
ITALY GI TESTING MARKET MARKET SIZE, VOLUME BY METHOD, TEST VOLUME AND SALES FORECASTS
JAPAN GI TESTING MARKET MARKET SIZE, VOLUME BY METHOD, TEST VOLUME AND SALES FORECASTS
SPAIN GI TESTING MARKET MARKET SIZE, VOLUME BY METHOD, TEST VOLUME AND SALES FORECASTS
U.K. GI TESTING MARKET MARKET SIZE, VOLUME BY METHOD, TEST VOLUME AND SALES FORECASTS
U.S.A. GI TESTING MARKET MARKET SIZE, VOLUME BY METHOD, TEST VOLUME AND SALES FORECASTS
COMPETITIVE ASSESSMENTS
Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic
Illumina
Leica Biosystems
Li-Cor Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
PerkinElmer
Proteome Sciences
Qiagen
Quest Diagnostics
Quidel
Roche
Scienion
Sequenom/LabCorp
Shimadzu
Siemens Healthineers
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
Wako Chemical